Insider Transactions Reported by 19 Insiders of BIORA THERAPEUTICS, INC.

Location
San Diego, CA

There are no Buy or Sell transactions made by insiders since 12 Feb 2025

BIORA THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Athyrium Opportunities Fund (A) LP 10%+ Owner $134,286,288 14 Jun 2021
Athyrium Capital Management, LP 10%+ Owner $134,286,288 14 Jun 2021
Harry Stylli Chairman & CEO, Director, 10%+ Owner $46,523,879 15 Aug 2021
Athyrium Opportunities III Co-Invest 1 LP Director, 10%+ Owner $1,129,408 12 Dec 2024
ADITYA P. MOHANTY Chief Executive Officer, Director $983,968 15 Aug 2024
Damon Silvestry President and General Manager, Avero $915,307 15 Nov 2021
Surbhi Sarna Director $467,150 03 Jan 2023
Matthew T. Cooper General Manager, Diagnostics $420,882 15 Nov 2021
Sami Shihabi Chief Commercial Officer $396,193 15 May 2021
Eric dEsparbes Chief Financial Officer $385,807 15 Aug 2024
Clarke Neumann Officer $311,928 15 Aug 2024
Troy Seelye Chief Information Officer $187,634 06 Aug 2021
John T. Bigalke Director $149,207 14 Jun 2021
SAMUEL R. NUSSBAUM MD Director $149,207 14 Jun 2021
Hutan Hashemi Chief Compliance Officer $89,474 15 Feb 2022
Jill A. Howe Director $60,966 05 Jun 2024
Jeffrey D. Alter Director $59,804 05 Jun 2024
Lynne Powell Director $57,292 05 Jun 2024
Brian L. Kotzin Director $57,292 05 Jun 2024

Recent Insider Transactions by Companies or Individuals for BIORA THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.